{
  "version": 1,
  "drugs": [
    {
      "id": "midazolam",
      "generic_name": "midazolam",
      "drug_class": "benzodiazepine",
      "therapeutic_index": "moderate",
      "aliases": [
        "versed"
      ],
      "notes": "Educational CYP3A4 substrate anchor.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "substrate",
          "fraction_metabolized": 0.6
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "CNS_depression",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "sedation/respiratory depression"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "short"
      }
    },
    {
      "id": "rifampin",
      "generic_name": "rifampin",
      "drug_class": "rifamycin antibiotic",
      "therapeutic_index": "moderate",
      "aliases": [
        "rifampicin"
      ],
      "notes": "Educational strong inducer anchor; time-course is clinically important.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "inducer",
          "strength": "strong"
        }
      ],
      "transporters": [
        {
          "transporter_id": "P-gp",
          "role": "inducer",
          "strength": "strong"
        }
      ],
      "pd_effects": [],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "clarithromycin",
      "generic_name": "clarithromycin",
      "drug_class": "macrolide antibiotic",
      "therapeutic_index": "moderate",
      "aliases": [
        "biaxin"
      ],
      "notes": "Educational strong CYP3A4 inhibitor and P-gp inhibitor anchor.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "inhibitor",
          "strength": "strong"
        }
      ],
      "transporters": [
        {
          "transporter_id": "P-gp",
          "role": "inhibitor",
          "strength": "strong"
        }
      ],
      "pd_effects": [
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "medium"
      }
    },
    {
      "id": "quetiapine",
      "generic_name": "quetiapine",
      "drug_class": "atypical antipsychotic",
      "therapeutic_index": "moderate",
      "aliases": [
        "seroquel"
      ],
      "notes": "CYP3A4 substrate used in strong inhibitor rule tests.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "substrate",
          "fraction_metabolized": 0.7
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "low"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "clopidogrel",
      "generic_name": "clopidogrel",
      "drug_class": "antiplatelet",
      "therapeutic_index": "moderate",
      "aliases": [
        "plavix"
      ],
      "notes": "Prodrug requiring CYP2C19 activation; inhibition reduces efficacy.",
      "enzymes": [
        {
          "enzyme_id": "CYP2C19",
          "role": "substrate",
          "fraction_metabolized": 0.7,
          "notes": "activation pathway (prodrug)"
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "bleeding",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": true,
        "active_metabolite": true,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "fluconazole",
      "generic_name": "fluconazole",
      "drug_class": "azole antifungal",
      "therapeutic_index": "moderate",
      "aliases": [
        "diflucan"
      ],
      "notes": "CYP2C9/2C19 inhibitor anchor.",
      "enzymes": [
        {
          "enzyme_id": "CYP2C19",
          "role": "inhibitor",
          "strength": "moderate"
        },
        {
          "enzyme_id": "CYP2C9",
          "role": "inhibitor",
          "strength": "moderate"
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "low"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": true,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "warfarin",
      "generic_name": "warfarin",
      "drug_class": "anticoagulant",
      "therapeutic_index": "narrow",
      "aliases": [
        "coumadin",
        "jantoven"
      ],
      "notes": "Narrow TI; classic CYP2C9 substrate.",
      "enzymes": [
        {
          "enzyme_id": "CYP2C9",
          "role": "substrate",
          "fraction_metabolized": 0.7
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "bleeding",
          "direction": "increase",
          "magnitude": "high"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "digoxin",
      "generic_name": "digoxin",
      "drug_class": "cardiac glycoside",
      "therapeutic_index": "narrow",
      "aliases": [
        "lanoxin"
      ],
      "notes": "P-gp substrate; narrow TI.",
      "enzymes": [],
      "transporters": [
        {
          "transporter_id": "P-gp",
          "role": "substrate"
        }
      ],
      "pd_effects": [
        {
          "effect_id": "bradycardia",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": true,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "verapamil",
      "generic_name": "verapamil",
      "drug_class": "calcium channel blocker",
      "therapeutic_index": "moderate",
      "aliases": [
        "calan",
        "verelan"
      ],
      "notes": "P-gp inhibitor used in transporter rules and dual mechanism scenarios.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "inhibitor",
          "strength": "moderate"
        }
      ],
      "transporters": [
        {
          "transporter_id": "P-gp",
          "role": "inhibitor",
          "strength": "moderate"
        }
      ],
      "pd_effects": [
        {
          "effect_id": "bradycardia",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "medium"
      }
    },
    {
      "id": "tizanidine",
      "generic_name": "tizanidine",
      "drug_class": "alpha-2 agonist muscle relaxant",
      "therapeutic_index": "moderate",
      "aliases": [
        "zanaflex"
      ],
      "notes": "Sensitive CYP1A2 substrate used in dedicated rule test.",
      "enzymes": [
        {
          "enzyme_id": "CYP1A2",
          "role": "substrate",
          "fraction_metabolized": 0.8
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "CNS_depression",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "short"
      }
    },
    {
      "id": "citalopram",
      "generic_name": "citalopram",
      "drug_class": "SSRI",
      "therapeutic_index": "moderate",
      "aliases": [
        "celexa"
      ],
      "notes": "QT additive PD rule anchor in tests.",
      "enzymes": [
        {
          "enzyme_id": "CYP2C19",
          "role": "substrate",
          "fraction_metabolized": 0.5
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "medium"
        },
        {
          "effect_id": "serotonergic",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "ondansetron",
      "generic_name": "ondansetron",
      "drug_class": "antiemetic (5-HT3 antagonist)",
      "therapeutic_index": "moderate",
      "aliases": [
        "zofran"
      ],
      "notes": "QT additive PD rule anchor in tests.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "substrate",
          "fraction_metabolized": 0.4
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "short"
      }
    },
    {
      "id": "sertraline",
      "generic_name": "sertraline",
      "drug_class": "SSRI",
      "therapeutic_index": "moderate",
      "aliases": [
        "zoloft"
      ],
      "notes": "Serotonergic PD stacking anchor.",
      "enzymes": [
        {
          "enzyme_id": "CYP2D6",
          "role": "inhibitor",
          "strength": "weak"
        }
      ],
      "transporters": [
        {
          "transporter_id": "P-gp",
          "role": "substrate"
        }
      ],
      "pd_effects": [
        {
          "effect_id": "serotonergic",
          "direction": "increase",
          "magnitude": "medium"
        },
        {
          "effect_id": "serotonin_syndrome",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "desvenlafaxine",
      "generic_name": "desvenlafaxine",
      "drug_class": "SNRI",
      "therapeutic_index": "moderate",
      "aliases": [
        "pristiq"
      ],
      "notes": "Serotonergic and BP/HR effects used in PD scenarios.",
      "enzymes": [],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "serotonin_syndrome",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": true,
        "half_life_bucket": "medium"
      }
    },
    {
      "id": "propranolol",
      "generic_name": "propranolol",
      "drug_class": "beta blocker",
      "therapeutic_index": "moderate",
      "aliases": [
        "inderal"
      ],
      "notes": "Bradycardia additive PD anchor.",
      "enzymes": [
        {
          "enzyme_id": "CYP2D6",
          "role": "substrate",
          "fraction_metabolized": 0.5
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "bradycardia",
          "direction": "increase",
          "magnitude": "medium"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "short"
      }
    },
    {
      "id": "cyclosporine",
      "generic_name": "cyclosporine",
      "drug_class": "calcineurin inhibitor",
      "therapeutic_index": "narrow",
      "aliases": [
        "neoral",
        "sandimmune"
      ],
      "notes": "Transporter inhibitor used in rosuvastatin BCRP/OATP tests.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "inhibitor",
          "strength": "moderate"
        }
      ],
      "transporters": [
        {
          "transporter_id": "BCRP",
          "role": "inhibitor",
          "strength": "strong"
        },
        {
          "transporter_id": "OATP1B1",
          "role": "inhibitor",
          "strength": "strong"
        },
        {
          "transporter_id": "P-gp",
          "role": "inhibitor",
          "strength": "strong"
        }
      ],
      "pd_effects": [],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "rosuvastatin",
      "generic_name": "rosuvastatin",
      "drug_class": "statin",
      "therapeutic_index": "moderate",
      "aliases": [
        "crestor"
      ],
      "notes": "BCRP and OATP substrate used in cyclosporine transporter tests.",
      "enzymes": [],
      "transporters": [
        {
          "transporter_id": "BCRP",
          "role": "substrate"
        },
        {
          "transporter_id": "OATP1B1",
          "role": "substrate"
        }
      ],
      "pd_effects": [],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": true,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "tacrolimus",
      "generic_name": "tacrolimus",
      "drug_class": "calcineurin inhibitor",
      "therapeutic_index": "narrow",
      "aliases": [
        "prograf"
      ],
      "notes": "Included for common transplant scenarios; CYP3A4 and P-gp substrate.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "substrate",
          "fraction_metabolized": 0.8
        }
      ],
      "transporters": [
        {
          "transporter_id": "P-gp",
          "role": "substrate"
        }
      ],
      "pd_effects": [],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "atazanavir",
      "generic_name": "atazanavir",
      "drug_class": "protease inhibitor",
      "therapeutic_index": "moderate",
      "aliases": [
        "reyataz"
      ],
      "notes": "UGT1A1 inhibitor used in irinotecan interaction scenario.",
      "enzymes": [
        {
          "enzyme_id": "UGT1A1",
          "role": "inhibitor",
          "strength": "strong"
        }
      ],
      "transporters": [],
      "pd_effects": [],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "irinotecan",
      "generic_name": "irinotecan",
      "drug_class": "topoisomerase inhibitor (chemo)",
      "therapeutic_index": "narrow",
      "aliases": [
        "camptosar"
      ],
      "notes": "UGT1A1 substrate (SN-38 glucuronidation); used with atazanavir.",
      "enzymes": [
        {
          "enzyme_id": "UGT1A1",
          "role": "substrate",
          "fraction_metabolized": 0.7
        }
      ],
      "transporters": [],
      "pd_effects": [],
      "parameters": {
        "prodrug": true,
        "active_metabolite": true,
        "renal_clearance_flag": false,
        "half_life_bucket": "short"
      }
    },
    {
      "id": "hydroxyzine",
      "generic_name": "hydroxyzine",
      "drug_class": "antihistamine",
      "therapeutic_index": "wide",
      "aliases": [
        "atarax",
        "vistaril",
        "hydroxyzine hcl",
        "hydroxyzine pamoate"
      ],
      "notes": "Sedating antihistamine; include CNS depression and QT effect for additive-risk PD logic. Enzyme data is educational placeholder.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "substrate",
          "fraction_metabolized": 0.3
        },
        {
          "enzyme_id": "CYP2D6",
          "role": "substrate",
          "fraction_metabolized": 0.2
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "CNS_depression",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "sedation"
        },
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "additive QT risk when combined with other QT-prolonging agents"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "medium"
      }
    },
    {
      "id": "paliperidone",
      "generic_name": "paliperidone",
      "drug_class": "antipsychotic",
      "therapeutic_index": "moderate",
      "aliases": [
        "invega",
        "invega sustenna",
        "invega trinza",
        "invega hafyera",
        "paliperidone er"
      ],
      "notes": "Antipsychotic; prioritize QT prolongation composite PD logic. Limited CYP contribution modeled here; primary handling is PD and renal clearance flag.",
      "enzymes": [],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "QT prolongation risk; additive with other QT-prolonging agents"
        },
        {
          "effect_id": "CNS_depression",
          "direction": "increase",
          "magnitude": "low",
          "mechanism_note": "sedation can be additive with other CNS depressants"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": true,
        "half_life_bucket": "medium"
      }
    },
    {
      "id": "lorazepam",
      "generic_name": "lorazepam",
      "drug_class": "benzodiazepine",
      "therapeutic_index": "moderate",
      "aliases": [
        "ativan",
        "lorazepam intensol"
      ],
      "notes": "Benzodiazepine; UGT substrate anchor for phase II logic. Primary interaction surface is additive CNS depression.",
      "enzymes": [
        {
          "enzyme_id": "UGT2B7",
          "role": "substrate",
          "fraction_metabolized": 0.7
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "CNS_depression",
          "direction": "increase",
          "magnitude": "high",
          "mechanism_note": "sedation/respiratory depression"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "medium"
      }
    },
    {
      "id": "olanzapine",
      "generic_name": "olanzapine",
      "drug_class": "antipsychotic",
      "therapeutic_index": "moderate",
      "aliases": [
        "zyprexa",
        "zyprexa zydis",
        "lybalvi"
      ],
      "notes": "Educational CYP1A2 substrate anchor for induction and inhibition rules. Include QT effect for additive-risk PD logic.",
      "enzymes": [
        {
          "enzyme_id": "CYP1A2",
          "role": "substrate",
          "fraction_metabolized": 0.5
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "CNS_depression",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "sedation"
        },
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "low",
          "mechanism_note": "possible QT effect; additive with other QT-prolonging agents"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "medium"
      }
    },
    {
      "id": "cariprazine",
      "generic_name": "cariprazine",
      "drug_class": "antipsychotic",
      "therapeutic_index": "moderate",
      "aliases": [
        "vraylar"
      ],
      "notes": "CYP3A4 substrate anchor for inhibitor and inducer rules. Long half-life bucket for persistence of effect.",
      "enzymes": [
        {
          "enzyme_id": "CYP3A4",
          "role": "substrate",
          "fraction_metabolized": 0.6
        },
        {
          "enzyme_id": "CYP2D6",
          "role": "substrate",
          "fraction_metabolized": 0.2
        }
      ],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "CNS_depression",
          "direction": "increase",
          "magnitude": "low",
          "mechanism_note": "sedation can be additive with other CNS depressants"
        },
        {
          "effect_id": "QT_prolongation",
          "direction": "increase",
          "magnitude": "low",
          "mechanism_note": "conservative flag for additive QT logic"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": true,
        "renal_clearance_flag": false,
        "half_life_bucket": "long"
      }
    },
    {
      "id": "methocarbamol",
      "generic_name": "methocarbamol",
      "drug_class": "muscle_relaxant",
      "therapeutic_index": "wide",
      "aliases": [
        "robaxin"
      ],
      "notes": "Muscle relaxant; primary interaction surface is additive CNS depression. PK modeled minimally for now.",
      "enzymes": [],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "CNS_depression",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "sedation/dizziness; additive with other CNS depressants"
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "short"
      }
    },
    {
      "id": "amphetamine_dextroamphetamine",
      "generic_name": "amphetamine and dextroamphetamine",
      "drug_class": "stimulant",
      "therapeutic_index": "wide",
      "aliases": [
        "adderall",
        "adderall xr",
        "mixed amphetamine salts",
        "amphetamine/dextroamphetamine",
        "amphetamine and dextroamphetamine",
        "amphetamine_dextroamphetamine"
      ],
      "notes": "Stimulant combination product; add PD effects only if you have PD rules for them (e.g., cardiovascular, hypertension).",
      "enzymes": [],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "CNS_stimulation",
          "direction": "increase",
          "magnitude": "high",
          "mechanism_note": "Stimulant; increases alertness and can cause insomnia/anxiety."
        },
        {
          "effect_id": "hypertension",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "Sympathomimetic; may increase blood pressure."
        },
        {
          "effect_id": "tachycardia",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "Sympathomimetic; may increase heart rate."
        },
        {
          "effect_id": "sympathetic_stimulation",
          "direction": "increase",
          "magnitude": "high",
          "mechanism_note": "Increased catecholaminergic tone; additive with other sympathomimetics."
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": false,
        "half_life_bucket": "medium"
      }
    },
    {
      "id": "pseudoephedrine",
      "generic_name": "pseudoephedrine",
      "drug_class": "decongestant",
      "therapeutic_index": "wide",
      "aliases": [
        "sudafed"
      ],
      "notes": "Sympathomimetic decongestant; increases blood pressure and heart rate.",
      "enzymes": [],
      "transporters": [],
      "pd_effects": [
        {
          "effect_id": "sympathetic_stimulation",
          "direction": "increase",
          "magnitude": "high",
          "mechanism_note": "Alpha and beta adrenergic agonism; increases catecholaminergic tone."
        },
        {
          "effect_id": "hypertension",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "Vasoconstriction may increase blood pressure."
        },
        {
          "effect_id": "tachycardia",
          "direction": "increase",
          "magnitude": "medium",
          "mechanism_note": "Beta-adrenergic stimulation may increase heart rate."
        }
      ],
      "parameters": {
        "prodrug": false,
        "active_metabolite": false,
        "renal_clearance_flag": true,
        "half_life_bucket": "medium"
      }
    }
  ]
}
